Neoadjuvant enfortumab vedotin promising in MIBC ineligible for cisplatin

Presented By
Prof. Daniel Petrylak, Yale School of Medicine, CT, USA
Trial
Phase 1/2, EV-103
Conference
ASCO GU 2022

Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-excerpt.php on line 93

Understanding MIBC biology for novel treatment options

Presented By
Prof. Yohann Loriot, Université Paris-Saclay, France
Trial
BLC2001; THOR; EV-301; EV-302; TROPHY-U-01; RANGE
Conference
EAU 2020

Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-excerpt.php on line 93

Enfortumab vedotin and pembrolizumab in advanced bladder cancer: initial results

Presented By
Prof. Christopher Hoimes, Case Comprehensive Cancer Center, Cleveland, USA
Trial
Phase 1, EV-103
Conference
ESMO 2019

Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-excerpt.php on line 93

Enfortumab vedotin highly active in previously treated advanced urothelial carcinoma

Presented By
Dr Daniel P. Petrylak, Yale School of Medicine, USA
Trial
EV-201, EV-301
Conference
ASCO 2019

Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-excerpt.php on line 93